Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark A. Perrella, M.D.

Co-Author

This page shows the publications co-authored by Mark Perrella and Sarah Chu.
Connection Strength

0.433
  1. Biobanking and cryopreservation of human lung explants for omic analysis. Eur Respir J. 2020 01; 55(1).
    View in: PubMed
    Score: 0.214
  2. Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts. Sci Rep. 2022 02 18; 12(1):2847.
    View in: PubMed
    Score: 0.062
  3. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021 08 01; 204(3):312-325.
    View in: PubMed
    Score: 0.059
  4. Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness. Am J Respir Cell Mol Biol. 2019 06; 60(6):659-666.
    View in: PubMed
    Score: 0.051
  5. Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148. Am J Respir Cell Mol Biol. 2018 02; 58(2):208-215.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.